Clinical trial
An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in…
NCT00141284 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141284 |
|---|---|
| Title | An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C |
| Official title | A Phase Iv Single-Arm Open-Label Non-Randomized Study To Evaluate The Safety And Pharmacokinetics Of Nelfinavir (Viracept, A430) 1250mg Twice Daily (250mg Or 625mg Forms) With Lamivudine/Zidovudine (Combivir) Background Therapy In Hiv/Hepatitis C Virus (Hcv) Co-Infected Subjects With Hepatic… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection, Hepatitis C |
| Intervention type | Drug |
| Interventions | nelfinavir 1, 250 mg twice daily, Zidovudine 300 mg twice daily, Lamivudine 150 mg twice daily |
| Enrollment | 12 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 1, 2005 |
| Last update posted | May 16, 2011 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: